Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 6
1985 2
1986 2
1987 2
1988 2
1989 2
1990 4
1991 3
1992 4
1993 2
1994 7
1995 13
1996 17
1997 15
1998 19
1999 27
2000 25
2001 24
2002 28
2003 32
2004 39
2005 36
2006 44
2007 52
2008 62
2009 85
2010 103
2011 107
2012 112
2013 126
2014 183
2015 205
2016 206
2017 246
2018 240
2019 312
2020 400
2021 487
2022 549
2023 564
2024 618
2025 514
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,990 results

Results by year

Filters applied: . Clear all
Page 1
Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging.
Zhang Z, Ma B, Li B, Li Z, Gao M, Zhao H, Peng R, Hu J, Wang Y, You W, Gui X, Wang R, Hu X, Chen B, Zhang Y, Hao Y, Sun X, Rao P, Zhang L, Lu M, Zhou D, Yang Y, Deng M, Miao L. Zhang Z, et al. Among authors: deng m. Cell Rep Med. 2025 Jul 15;6(7):102209. doi: 10.1016/j.xcrm.2025.102209. Epub 2025 Jul 1. Cell Rep Med. 2025. PMID: 40602406 Free PMC article.
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial.
Chen XC, Jiao DC, Qiao JH, Wang CZ, Sun XF, Lu ZD, Li LF, Zhang CJ, Yan M, Wei Y, Chen B, Feng YQ, Deng M, Ma MD, Plichta JK, He YW, Liu ZZ. Chen XC, et al. Among authors: deng m. Lancet Oncol. 2025 Jan;26(1):27-36. doi: 10.1016/S1470-2045(24)00581-3. Epub 2024 Nov 26. Lancet Oncol. 2025. PMID: 39612919 Clinical Trial.
4,990 results